Central Blood Volume in Hypotensive Dialysis Patients

This study has been completed.
Information provided by:
Danish State Hospital
ClinicalTrials.gov Identifier:
First received: November 21, 2005
Last updated: September 11, 2006
Last verified: September 2006
The purpose of the study is to test whether hypotensive episodes during dialysis - caused by withdrawal of fluid drom the circulation - can be predicted by means of two harmless monitoring techniques.

Intradialytic Hypotension

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Registration of Central Blood Volume in Hypotensive Dialysis Patients - a Comparison of Thoracic Impedance and Central Venous Saturation Monitoring

Resource links provided by NLM:

Further study details as provided by Danish State Hospital:

Estimated Enrollment: 20
Study Start Date: November 2005
Estimated Study Completion Date: May 2006

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both

Inclusion Criteria:

  • Chronic hemodialysis patients with central vascular access

Exclusion Criteria:

  • Patients below 18 years of age
  • Patients unable to give informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00257504

Danish State Hospital
Copenhagen, Denmark, 2100
Sponsors and Collaborators
Danish State Hospital
Study Director: Søren D Ladefoged, MD Danish State Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00257504     History of Changes
Other Study ID Numbers: CBV estimation 
Study First Received: November 21, 2005
Last Updated: September 11, 2006
Health Authority: Denmark: National Board of Health

Additional relevant MeSH terms:
Cardiovascular Diseases
Vascular Diseases
Antihypertensive Agents
Cardiovascular Agents
Pharmacologic Actions
Therapeutic Uses

ClinicalTrials.gov processed this record on April 27, 2016